Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

30 results about "Dosage form" patented technology

Dosage forms (also called unit doses) are pharmaceutical drug products in the form in which they are marketed for use, with a specific mixture of active ingredients and inactive components (excipients), in a particular configuration (such as a capsule shell, for example), and apportioned into a particular dose. For example, two products may both be amoxicillin, but one is in 500 mg capsules and another is in 250 mg chewable tablets. The term unit dose can also sometimes encompass non-reusable packaging as well (especially when each drug product is individually packaged), although the FDA distinguishes that by unit-dose "packaging" or "dispensing". Depending on the context, multi(ple) unit dose can refer to distinct drug products packaged together, or to a single drug product containing multiple drugs and/or doses. The term dosage form can also sometimes refer only to the pharmaceutical formulation of a drug product's constituent drug substance(s) and any blends involved, without considering matters beyond that (like how it is ultimately configured as a consumable product such as a capsule, patch, etc.). Because of the somewhat vague boundaries and unclear overlap of these terms and certain variants and qualifiers within the pharmaceutical industry, caution is often advisable when conversing with someone who may be unfamiliar with another person's use of the term.

Traditional Chinese medicine compound pharmaceutical composition used for laying fowls and preparation method and application thereof

ActiveCN101744923APromote dissolutionPromote absorptionAnimal feeding stuffSexual disorderSalvia miltiorrhizaSide effect
The invention relates to a traditional Chinese medicine compound pharmaceutical composition and a preparation method and application thereof. The traditional Chinese medicine compound pharmaceutical composition contains clove, Salvia miltiorrhiza, dodder, epimedium, fructus cnidii, radix codonopsitis, radix astragali, angelica, rhizoma ligustici wallichii, phellodendron, radix scutellariae, rhizoma coptidis, Gardenia, ebony, hawthorn and kaki calyx. The traditional Chinese medicine compound pharmaceutical composition has the efficacies of replenishing Qi to invigorate the spleen, warming uterus and tonifying Yang, tonifying kidney and consolidating, nourishing blood and tonifying Qi, activating blood flow and removing blood stasis and clearing heat and detoxicating and has the functions of preventing and curing the inflammations of the fallopian tubes of the laying fowls. The traditional Chinese medicine compound pharmaceutical composition has definite curative effect, rapid action, safe use and no toxic and side effects or residuals, meets the demand of safety of animal-derived foods, is easy to realize industrial production and does not have pollution on the environment. The invention also provides a preparation method of the traditional Chinese medicine compound pharmaceutical composition and the application of preventing and curing the inflammations of the fallopian tubes of the laying fowls and improving the laying function. The traditional Chinese medicine compound pharmaceutical composition can be a powder. The invention also provides a feed containing the traditional Chinese medicine compound pharmaceutical composition.
Owner:BEIJING DABEINONG ANIMAL HEALTH TECH +1

TCM composition curing chloasma and preparation method thereof

ActiveCN107714798ARegulate immunityPromote circulationDermatological disorderAntineoplastic agentsPigmentationsLiquorices
The invention provides a TCM composition curing chloasma and a preparation method thereof, relating to the technical field of traditional Chinese medicines. The TCM composition curing chloasma is mainly prepared from the following raw materials in parts by weight: ramulus cinnamomi, poria cocos, peach kernel, radix paeoniae rubra, radix paeoniae alba, cortex Moutan, radix angelicae sinensis, radixbupleuri, white atractylodes rhizome, liquorice root, herba menthae, rose flower, flos carthami and mume flower. The TCM composition is safe to use and can lighten or eliminate facial pigmentation soas to improve the skin and improve live quality. The preparation method for the TCM composition comprises the steps of drying and smashing raw materials and then mixing with auxiliary materials. Thepreparation method is easy to carry out, has strong operability, mains the medicine effect, and is suitable for industrial production. The TCM composition is changed in dosage form, thereby being convenient to carry and take by patients on time.
Owner:HENAN PROVINCE HOSPITAL OF TCM THE SECOND AFFILIATED HOSPITAL OF HENAN UNIV OF TCM

Lung cancer and breast cancer treatment compound preparation containing active ingredients of traditional Chinese medicine and preparation method of lung cancer and breast cancer compound preparation

InactiveCN105079005AGood inhibitory effectHigh anticancer activityEther/acetal active ingredientsRespiratory disorderPolyethylene glycolIn vivo
The invention discloses a lung cancer and breast cancer treatment compound preparation containing active ingredients of traditional Chinese medicine and a preparation method of the lung cancer and breast cancer compound preparation. The lung cancer and breast cancer treatment compound preparation is made from erianin, taxol, bufalin and bruceine D according to a certain weight ratio. According to the preparation method, liposomes are prepared according to an ethyl alcohol injection method or dropping pills are prepared by taking polyethylene glycol as a base material to obtain the lung cancer and breast cancer treatment compound preparation containing the active ingredients of the traditional Chinese medicine. The form of the compound preparation is compound liposomes and compound dripping pills. According to animal in-vivo anticancer pharmacological experiments, the lung cancer and breast cancer treatment compound preparation containing the active ingredients of the traditional Chinese medicine has obvious inhibiting effect on growth of lung cancer and breast cancer and has higher anticancer activity than chemotherapeutic drug 5-fluorouracil.
Owner:NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE

Preparing method of angelica-Longhui soft capsule

The present invention relates to medicine technology, and is especially preparation process of angelica-Longhui soft capsule. Angelica-Longhui soft capsule has the same functions as available angelica-Longhui bolus, angelica-Longhui tablet, etc. and is superior in that it has raised medicine releasing speed and prolonged storing period.
Owner:SHANGHAI YOUSEEN NEW MEDICINE EXPLOITION

Method for preparing Qingkailing capsules

InactiveCN101601754APromote absorptionImprove bioavailabilityNervous disorderAntipyreticSuspending AgentsCalculus bovis
The invention belongs to the technical field of medicine, in particular to a method for preparing Qingkailing capsules. The method concretely comprises the following steps: grinding calculus bovis, buffalo horns and nacre into fine powder and sieving for standby; adding water into other medicaments, decocting the medicaments by two times for 4 hours each time; merging and filtering decoction liquors; concentrating the obtained filter liquor into thick paste; uniformly mixing the thick paste with the fine powder, drying and grinding into fine powder for standby; adding 0.5-10 portions of suspending agents into 20-80 portions of matrixes, heating and mixing to prepare beewax oil; adding the obtained traditional Chinese medicine fine powder into the beewax oil and uniformly stirring; preparing soft capsule shells according to a conventional method, putting the soft capsule shells in a soft capsule machine for automatic packing so as to prepare soft capsules.
Owner:SHANGHAI YOUSEEN NEW MEDICINE EXPLOITION

Transdermal or transmucosal dosage forms with a nicotine-containing active substance combination for smoker disintoxication

InactiveCN1423556AAvoid oralFit closelyOrganic active ingredientsNervous disorderNicotineCentral nervous system
A transdermal or transmucosal pharmaceutical administration form for treating nicotine dependency or for disaccustoming smokers, comprising nicotine, a nicotine salt, a nicotine derivative or a nicotinergic substance in combination with at least one further active substance is characterized in that as additional active substance(s) it comprises at least one substance which acts on the central nervous system.
Owner:LTS LOHMANN THERAPIE-SYST AG

Traditional Chinese medicine composition and preparation method thereof

InactiveCN101658588AImprove the vitality of retinal nerve cellsConducive to the active ingredients and pharmacodynamic mechanism of traditional Chinese medicineSenses disorderMetabolism disorderSalviaDosage form
The invention discloses a traditional Chinese medicine composition and a preparation method thereof, more particularly provides a traditional Chinese medicine composition for treating diabetic retinopathy and a preparation method thereof. The traditional Chinese medicine composition contains rehmannia, the root of red-rooted salvia, ginseng and the root of kudzu vine, and can be made into any common preparation formulation. The traditional Chinese medicine composition has remarkable effect on controlling the diabetic retinopathy, and is obvious in the effect of protecting retinal neurons, improving retinal ganglion cell activity, etc.
Owner:CHENGDU UNIV OF TRADITIONAL CHINESE MEDICINE

Controllable hydrogen production composite material and application thereof

InactiveCN111924801AGood application effectHigh reducing activityHydrogen productionFood additiveDrug additive
The invention relates to a controllable hydrogen production composite material and application thereof. The controllable hydrogen production composite material comprises a hydrogen production agent, acontrolled release agent and a hydrogen molecule activating agent, wherein the mass fraction of the hydrogen production agent is 1-100%, the mass fraction of the controlled release agent is 0-99%, the mass fraction of the hydrogen molecule activating agent is 0-30%, the hydrogen production agent has high hydrogen production capacity, the controlled release agent can effectively regulate the hydrogen production speed, and the hydrogen molecule activating agent can improve the activity of hydrogen molecules and efficiently play a role in hydrogen molecular biology. The controllable hydrogen production composite material can be prepared into multiple dosage forms such as compound powder, capsules, tablets, electuary or spray, can be used as a cosmetic additive, a beverage additive, a food additive, a feed additive, a plant growth regulator and a drug additive, and is widely applied to daily maintenance, functional health care, hydrogen medicine and hydrogen agriculture.
Owner:SHENZHEN HIXIN TECH CO LTD

Improved medicinal compositions comprising buprenorphine and naltrexone

InactiveCN101622014AOrganic active ingredientsNervous disorderBlood plasmaMucous membrane
An analgesic composition, in parenteral unit dosage form or in a unit dosage form suitable for delivery via the dermis or mucosa, comprises buprenorphine and an amount of naltrexone such that the ratio by weight of buprenorphine to naltrexone delivered to or reaching the plasma of a patient is in the range 100:1 to 5000:1. The analgesic action of the buprenorphine is potentiated by the low dose of naltrexone. Also provided are a method of treatment of pain and the use of buprenorphine and naltrexone for the manufacture of a medicament.
Owner:RB PHARMA

Pharmaceutical composition for treating gynecologic diseases and preparation method thereof

ActiveCN103417587AHigh antibacterial efficiencyEasy to useAntibacterial agentsAntimycoticsGynecologic DiseasesActive matter
The invention aims to provide a pure natural oceanic biological pharmaceutical composition which adopts brand-new oceanic biological active matters, is made by scientific components, and is high in antibacterial efficiency. The pharmaceutical composition mainly comprises medical chitosan, Eucheuma gelatinae, clam, and caloglossa. The invention further provides a preparation method of the pharmaceutical composition, the medical production formulation of the pharmaceutical composition, and application of the pharmaceutical composition in gynecologic drugs. The pharmaceutical composition extracted from natural oceanic animals and plants is nontoxic, stimulation-free, immune-antigenicity-free and good in histocompatibility, and is natural high-molecular compound which can be degraded and absorbed in bodies. The external preparation made by the pharmaceutical composition is convenient to use, high in antibacterial efficiency, capable of promoting epithelial cell growing and gynecologic physiological acid-base balance, and applicable to various gynecologic disease treating processes such as wound repair, bleeding stopping, bacteria inhibition and inflammation diminishing, packing after operation, and interventional therapy.
Owner:GUANGZHOU TENGJIAN MARINE LIFE SCI TECH

Herbicide composition containing flucarbazone

InactiveCN106962388ASynergisticReduce dosageBiocideAnimal repellantsEcological environmentPESTICIDE ADJUVANTS
The invention discloses a wheat paddock weeding composition which comprises halauxifen-methyl, bentazone, flucarbazone and the rest pesticide adjuvant serving as effective components. The weight ratio of the halauxifen-methyl, the bentazone to the flucarbazone is (0.5-8):(47.5-760):(2.5-40), and the weight percentage of active components in the weeding composition is 10-95%. According to application requirements, the weeding composition can be prepared into dosage forms such as wettable powder, water dispersible granules, suspending agents and dispersible oil suspending agents. The wheat paddock weed control effect of the composition is better than that of individual use of the halauxifen-methyl, the bentazone and the flucarbazone, dosage of pesticides is decreased, the adverse effect of the pesticides on an ecological environment is reduced, and the problem of drug resistance of weeds is effectively solved.
Owner:SHANDONG BINNONG TECH

Medicine composition for treating psoriasis

InactiveCN106902258AAnthropod material medical ingredientsPill deliveryRealgarPsoriasis universalis
The invention discloses a pharmaceutical composition for treating psoriasis, which is composed of 23 raw materials such as vitex, nepeta, pangolin, snail, alum, realgar, catechu, gypsum, angelica, and frankincense. The pharmaceutical composition of the present invention is prepared into any clinically acceptable dosage form by adding conventional auxiliary materials according to conventional techniques. The pharmaceutical composition of the invention has remarkable effect on treating psoriasis, treats both symptoms and root causes, has low recurrence rate, moderate cost and can be accepted by common patients.
Owner:邵杰
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products